Association of Retinal Neurodegeneration on Optical Coherence Tomography with Dementia: A Population-Based Study

JAMA Neurology

Volumn 75, Issue 10, 2018, Pages 1256-1263

  Mutlu, Unal ^a   Colijn, Johanna M ^a   Ikram, M Arfan ^a   Bonnemaijer, Pieter W M ^a   Licher, Silvan ^a   Wolters, Frank J ^a   Tiemeier, Henning ^a   Koudstaal, Peter J ^a   Klaver, Caroline C W ^a,b   Ikram, M Kamran ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGE; ALZHEIMER DISEASE; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; DUTCHMAN; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; GLAUCOMA; HIGH RISK PATIENT; HUMAN; HYPERMETROPIA; HYPERTENSION; INCIDENCE; MACULAR DEGENERATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYOPIA; NERVE DEGENERATION; OPTIC DISK; OPTICAL COHERENCE TOMOGRAPHY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA DEGENERATION; RETINAL NERVE FIBER LAYER THICKNESS; RETINOPATHY; SEX; AGED; DIAGNOSTIC IMAGING; NERVE FIBER; NETHERLANDS; PATHOLOGY; RETINA GANGLION CELL; RETINA NERVE CELL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DEMENTIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NERVE DEGENERATION; NERVE FIBERS; NETHERLANDS; RETINAL GANGLION CELLS; RETINAL NEURONS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 85053847816     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2018.1563     Document Type: Article

References (34)

1. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013; 9 (1): 63-75.e2. 23305823
2. Sperling RA, Aisen PS, Beckett LA, Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7 (3): 280-292. doi: 10.1016/j.jalz.2011.03.003 21514248
3. Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV, Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage. 2011; 54 (suppl 1): S204-S217. doi: 10.1016/j.neuroimage.2010.06.020 20550967
4. Koronyo Y, Biggs D, Barron E, Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease. JCI Insight. 2017; 2 (16): 93621. doi: 10.1172/jci.insight.93621 28814675
5. McGrory S, Cameron JR, Pellegrini E, The application of retinal fundus camera imaging in dementia: a systematic review. Alzheimers Dement (Amst). 2016; 6: 91-107. 28229127
6. Hart NJ, Koronyo Y, Black KL, Koronyo-Hamaoui M. Ocular indicators of Alzheimer's: exploring disease in the retina. Acta Neuropathol. 2016; 132 (6): 767-787. doi: 10.1007/s00401-016-1613-6 27645291
7. Javaid FZ, Brenton J, Guo L, Cordeiro MF. Visual and ocular manifestations of Alzheimer's disease and their use as biomarkers for diagnosis and progression. Front Neurol. 2016; 7: 55. doi: 10.3389/fneur.2016.00055 27148157
8. Coppola G, Di Renzo A, Ziccardi L, Optical coherence tomography in Alzheimer's disease: a meta-analysis. PLoS One. 2015; 10 (8): e0134750. doi: 10.1371/journal.pone.0134750 26252902
9. den Haan J, Verbraak FD, Visser PJ, Bouwman FH. Retinal thickness in Alzheimer's disease: a systematic review and meta-analysis. Alzheimers Dement (Amst). 2017; 6: 162-170. 28275698
10. Cheung CY, Ong YT, Hilal S, Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis. 2015; 45 (1): 45-56. 25428254
11. Choi SH, Park SJ, Kim NR. Macular ganglion cell -inner plexiform layer thickness is associated with clinical progression in mild cognitive impairment and Alzheimers disease. PLoS One. 2016; 11 (9): e0162202. doi: 10.1371/journal.pone.0162202 27598262
12. Marziani E, Pomati S, Ramolfo P, Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer's disease using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2013; 54 (9): 5953-5958. doi: 10.1167/iovs.13-12046 23920375
13. Ong YT, Hilal S, Cheung CY, Retinal neurodegeneration on optical coherence tomography and cerebral atrophy. Neurosci Lett. 2015; 584: 12-16. doi: 10.1016/j.neulet.2014.10.010 25451722
14. Mutlu U, Bonnemaijer PWM, Ikram MA, Retinal neurodegeneration and brain MRI markers: the Rotterdam Study. Neurobiol Aging. 2017; 60: 183-191. doi: 10.1016/j.neurobiolaging.2017.09.003 28974335
15. Hofman A, Brusselle GG, Darwish Murad S, The Rotterdam Study: 2016 objectives and design update. Eur J Epidemiol. 2015; 30 (8): 661-708. doi: 10.1007/s10654-015-0082-x 26386597
16. Terry L, Cassels N, Lu K, Automated retinal layer segmentation using spectral domain optical coherence tomography: evaluation of inter-session repeatability and agreement between devices. PLoS One. 2016; 11 (9): e0162001. doi: 10.1371/journal.pone.0162001 27588683
17. Lee K, Buitendijk GH, Bogunovic H, Automated segmentability index for layer segmentation of macular SD-OCT images. Transl Vis Sci Technol. 2016; 5 (2): 14. doi: 10.1167/tvst.5.2.14 27066311
18. Tewarie P, Balk L, Costello F, The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS One. 2012; 7 (4): e34823. doi: 10.1371/journal.pone.0034823 22536333
19. Cruz-Herranz A, Balk LJ, Oberwahrenbrock T,; IMSVISUAL consortium. The APOSTEL recommendations for reporting quantitative optical coherence tomography studies. Neurology. 2016; 86 (24): 2303-2309. doi: 10.1212/WNL.0000000000002774 27225223
20. Patel PJ, Foster PJ, Grossi CM,; UK Biobank Eyes and Vision Consortium. Spectral-domain optical coherence tomography imaging in 67 321 adults: associations with macular thickness in the UK Biobank Study. Ophthalmology. 2016; 123 (4): 829-840. doi: 10.1016/j.ophtha.2015.11.009 26746598
21. Keane PA, Grossi CM, Foster PJ,; UK Biobank Eye Vision Consortium. Optical coherence tomography in the UK Biobank Study: rapid automated analysis of retinal thickness for large population-based studies. PLoS One. 2016; 11 (10): e0164095. doi: 10.1371/journal.pone.0164095 27716837
22. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984; 34 (7): 939-944. doi: 10.1212/WNL.34.7.939 6610841
23. Román GC, Tatemichi TK, Erkinjuntti T, Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN international workshop. Neurology. 1993; 43 (2): 250-260. doi: 10.1212/WNL.43.2.250 8094895
24. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982; 140: 566-572. doi: 10.1192/bjp.140.6.566 7104545
25. Hoogendam YY, Hofman A, van der Geest JN, van der Lugt A, Ikram MA. Patterns of cognitive function in aging: the Rotterdam Study. Eur J Epidemiol. 2014; 29 (2): 133-140. doi: 10.1007/s10654-014-9885-4 24553905
26. Hinton DR, Sadun AA, Blanks JC, Miller CA. Optic-nerve degeneration in Alzheimer's disease. N Engl J Med. 1986; 315 (8): 485-487. doi: 10.1056/NEJM198608213150804 3736630
27. Blanks JC, Hinton DR, Sadun AA, Miller CA. Retinal ganglion cell degeneration in Alzheimer's disease. Brain Res. 1989; 501 (2): 364-372. doi: 10.1016/0006-8993(89)90653-7 2819446
28. Rovere G, Nadal-Nicolás FM, Agudo-Barriuso M, Comparison of retinal nerve fiber layer thinning and retinal ganglion cell loss after optic nerve transection in adult albino rats. Invest Ophthalmol Vis Sci. 2015; 56 (8): 4487-4498. doi: 10.1167/iovs.15-17145 26193926
29. Abbott CJ, Choe TE, Lusardi TA, Burgoyne CF, Wang L, Fortune B. Evaluation of retinal nerve fiber layer thickness and axonal transport 1 and 2 weeks after 8 hours of acute intraocular pressure elevation in rats. Invest Ophthalmol Vis Sci. 2014; 55 (2): 674-687. doi: 10.1167/iovs.13-12811 24398096
30. Vidal-Sanz M, Galindo-Romero C, Valiente-Soriano FJ, Shared and differential retinal responses against optic nerve injury and ocular hypertension. Front Neurosci. 2017; 11: 235. doi: 10.3389/fnins.2017.00235 28491019
31. Koronyo Y, Salumbides BC, Black KL, Koronyo-Hamaoui M. Alzheimer's disease in the retina: imaging retinal aβ plaques for early diagnosis and therapy assessment. Neurodegener Dis. 2012; 10 (1-4): 285-293. doi: 10.1159/000335154 22343730
32. Ning A, Cui J, To E, Ashe KH, Matsubara J. Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Invest Ophthalmol Vis Sci. 2008; 49 (11): 5136-5143. doi: 10.1167/iovs.08-1849 18566467
33. Jiang J, Wang H, Li W, Cao X, Li C. Amyloid plaques in retina for diagnosis in Alzheimer's patients: a meta-analysis. Front Aging Neurosci. 2016; 8: 267. doi: 10.3389/fnagi.2016.00267 27891091
34. Cameron JR, Megaw RD, Tatham AJ, Lateral thinking: interocular symmetry and asymmetry in neurovascular patterning, in health and disease. Prog Retin Eye Res. 2017; 59: 131-157. doi: 10.1016/j.preteyeres.2017.04.003 28457789